Hi Everyone -
🥸Here are all the 27 late breaking clinical trials presented at @ACCinTouch (ACC.26) with session number, day, time, and objective.
😱See you in NOLA:
👇👇👇
Would you like some expert recommendations for anticoagulation in atrial fibrillation and DVT/PE when it happens in #cirrhosis?
Yes?
Here you go
https://t.co/pQCVztyNzq
#livertwitter
Join us Tues 9/7 2pm ET & learn about "Reducing Health Disparities—Achieving Pharmacoequity" Dr. Utibe R. Essien will walk u thru how to provide equitable access to care & diminish racial disparities - this free seminar is ethics accredited
Register now! https://t.co/T2HkIwn02X
The standards, competencies, & clinical data relating to the use of device therapy in heart failure (HF) continue to evolve rapidly. Join us for HF Seminar on devices. #hfsa#heartfailure#CardioEd#MedEd#SoMe#cardiotwitter
Register at>> https://t.co/WB4QHulN5S
Based on some recent Twitter debates, went back to review some of the data on CT Calcium Scoring as a predictor of MACE.
Here's what I found...in a super long series of 🧵s
PART I
#cvPrev#powerofzero#YesCCT#ACCFIT#AHAFIT#cardiotwitter
Do you ❤️ hemodynamics? How about PV loops?
Here is Part I of our journey to to help YOU better understand PV loops and make them a little less daunting. Couldn't have done this without ⭐ @TJUHospital resident @jayamj94, and edits from @PSullivan000. Stay tuned for Part 2!
🆕 statement explores past, present & future of surgical management of high-risk PE, a leading cause of CV death in the U.S.: https://t.co/t6tzeji5qn #STS2023
📷 Effect of a hemodynamically significant PE on biventricular function
✍️ @GoldbergJBCTMD@jaygirimd
📖 @CircAHA
As a Cardiology fellow, we get a lot of consults for Cardiogenic Shock.
Part 1: Definition/Pathophysiology.
*Not to use as medical advice, just tips, and always discuss with your fellow/attending*
-thread 🧵-
#MedTwitter#MedEd#Cardiotwitter#IMG